Marken, the UPS subsidiary that specializes in clinical supply storage and delivery, is planning multiple expansions in Europe, Asia and South America:
- Marken Korea’s new Clinical Supply Center (depot) will be 1,792 sq. m. of GMP-compliant space located near the Gimpo airport. It will operate with a Wholesale Dealers License (WDL) and will be fully operational by Q2 2020.
- A new Ukraine depot is located within 10 km of the Boryspil International Airport, near the capital city of Kiev. It will be 1,350 sq. m. of GMP-compliant space and will be operational in 2Q 2020.
- The existing Frankfurt Clinical Supply Center will soon accommodate storage of highly sensitive GMO, human cells and gene therapies under ultra-low (-150°C) temperatures. The storage unit will occupy space inside the existing depot facility and will be operational by Q1 2020.
- Marken is also building a new Clinical Distribution Center near Bogota, Columbia. The facility will be built inside of an existing 76,000-sq. ft. UPS healthcare warehouse.
With these additions, Marken will have a network of 12 fully owned and 12 partner GMP depot locations. Overall, there are depots or logistic hubs in 54 locations worldwide for clinical trial material storage and distribution. The company manages 85,000 drug and biological shipments monthly in more than 150 countries. Additional services include biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy.